Copyright © Inderes 2011 - present. All rights reserved.
Log in to your Inderes Free account to see all free content on this page.
Create account

Stayble Therapeutics

0.25 SEK

Less than 1K followers

STABL

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

-12.59 %
+3.26 %
-27.47 %
-46.06 %
-50.29 %
-53.91 %
-93.60 %
-96.46 %
-96.61 %

Stayble Therapeutics operates in the pharmaceutical industry. The company specializes in research and development of injection treatments for pain caused by herniated discs. The drug candidates are developed and based on a proprietary technological platform. Most operations are found in the Nordic market and the company has its headquarters in Gothenburg.

Read more
Market cap
16.32M SEK
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
25.2.
2026

Annual report '25

ShowingAll content types
Third party research

Stayble Therapeutics: Rapportkommentar Q2'25 - Kalqyl

Stayble Therapeutics redovisade ingen nettoomsättning och en minskad rörelseförlust under det andra kvartalet. Nettoomsättningen uppgick till 0,0 MSEK (0,0), medan övriga rörelseintäkter landade på 0,0 MSEK (0,4). EBIT uppgick till -1,9 MSEK (-3,4). ...

Stayble Therapeutics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.